CAHEX
Price
$20.49
Change
-$0.06 (-0.29%)
Updated
Sep 14 closing price
Net Assets
891.05M
GATEX
Price
$54.01
Change
-$0.22 (-0.41%)
Updated
Sep 14 closing price
Net Assets
7.34B
Interact to see
Advertisement

CAHEX vs GATEX

CAHEX vs GATEX Comparison Chart in %
View a ticker or compare two or three
VS
CAHEX vs. GATEX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAHEX is a Buy and GATEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GATEX has more cash in the bank: 7.34B vs. CAHEX (891M). GATEX pays higher dividends than CAHEX: GATEX (0.18) vs CAHEX (0.13). CAHEX was incepted earlier than GATEX: CAHEX (12 years) vs GATEX (49 years). CAHEX (1.15) is less costly to investors than GATEX (0.97). GATEX is a more actively managed with annual turnover of: 17.00 vs. CAHEX (10.00). GATEX initial investment is less costly to investors than CAHEX (5%) vs CAHEX (5%). CAHEX (2500) and GATEX (2500) have matching initial minimum investment requirements. CAHEX (9.90) and GATEX (9.50) have marching annual gain over last year. CAHEX return over 5 years is better than : 43.53 vs. GATEX (38.15).
CAHEXGATEXCAHEX / GATEX
Total Expense Ratio1.150.94122%
Annual Report Gross Expense Ratio1.150.97119%
Fund Existence12 years49 years-
Gain YTD6.9426.313110%
Front Load5%6%83%
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets891M7.34B12%
Annual Yield % from dividends0.130.1874%
Returns for 1 year9.909.50104%
Returns for 3 years43.1438.39112%
Returns for 5 years43.5338.15114%
Returns for 10 years112.8186.23131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDVCX12.880.01
+0.08%
Nomura Value C
TRGPX20.10N/A
N/A
Nuveen Quant Mid Cap Growth Premier
PMVQX34.06N/A
N/A
PGIM Quant Solutions Mid-Cap Val R6
JIGTX39.24N/A
N/A
JHancock International Growth R6
EEMIX12.84N/A
N/A
MFS Emerging Markets Equity Research I